Ribavirin concentration in the later stages of 48 week pegylated interferon-α2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response

Norihiro Furusyo*, Masayuki Murata, Eiichi Ogawa, Kazuhiro Toyoda, Takeshi Ihara, Hiroaki Ikezaki, Takeo Hayashi, Tsunehisa Koga, Mosaburo Kainuma, Jun Hayashi

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Ribavirin concentration in the later stages of 48 week pegylated interferon-α2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences